Physicians Financial Services Inc. lowered its stake in shares of Clorox Company (The) (NYSE:CLX) by 0.2% during the second quarter, according to its most recent filing with the SEC. The fund owned 9,060 shares of the company’s stock after selling 20 shares during the period. Physicians Financial Services Inc.’s holdings in Clorox Company (The) were worth $1,207,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in CLX. Jacobi Capital Management LLC boosted its stake in shares of Clorox Company (The) by 0.3% in the first quarter. Jacobi Capital Management LLC now owns 1,282 shares of the company’s stock valued at $172,000 after buying an additional 4 shares during the period. Bridgeworth LLC boosted its stake in shares of Clorox Company (The) by 0.3% in the first quarter. Bridgeworth LLC now owns 1,869 shares of the company’s stock valued at $252,000 after buying an additional 5 shares during the period. Valley National Advisers Inc. boosted its stake in shares of Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock valued at $116,000 after buying an additional 5 shares during the period. Blue Chip Partners Inc. boosted its stake in shares of Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock valued at $122,000 after buying an additional 6 shares during the period. Finally, Wade G W & Inc. boosted its stake in shares of Clorox Company (The) by 0.3% in the first quarter. Wade G W & Inc. now owns 3,173 shares of the company’s stock valued at $428,000 after buying an additional 8 shares during the period. 69.83% of the stock is currently owned by institutional investors and hedge funds.

Shares of Clorox Company (NYSE:CLX) opened at 135.57 on Tuesday. The firm has a market capitalization of $17.50 billion, a P/E ratio of 25.41 and a beta of 0.40. Clorox Company has a 12 month low of $111.24 and a 12 month high of $141.76. The firm’s 50-day moving average price is $133.48 and its 200 day moving average price is $133.84.

Clorox Company (The) (NYSE:CLX) last announced its earnings results on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, beating analysts’ consensus estimates of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The business had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.65 billion. During the same period in the prior year, the company earned $1.30 earnings per share. The business’s revenue was up 2.9% compared to the same quarter last year. Analysts anticipate that Clorox Company will post $5.67 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Physicians Financial Services Inc. Sells 20 Shares of Clorox Company (The) (CLX)” was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this news story on another site, it was copied illegally and republished in violation of international trademark & copyright laws. The legal version of this news story can be read at https://www.watchlistnews.com/physicians-financial-services-inc-sells-20-shares-of-clorox-company-the-clx/1488980.html.

Several analysts have issued reports on the company. UBS AG reaffirmed a “sell” rating and set a $121.00 target price (up previously from $117.00) on shares of Clorox Company (The) in a research report on Friday, May 5th. Jefferies Group LLC reiterated a “hold” rating and set a $137.00 price objective (up previously from $136.00) on shares of Clorox Company (The) in a report on Wednesday, August 9th. Royal Bank Of Canada set a $115.00 price objective on Clorox Company (The) and gave the company a “hold” rating in a report on Monday, April 24th. Vetr lowered Clorox Company (The) from a “buy” rating to a “hold” rating and set a $139.67 price objective for the company. in a report on Tuesday, April 18th. Finally, BidaskClub upgraded Clorox Company (The) from a “strong sell” rating to a “sell” rating in a report on Monday, July 31st. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $129.05.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.